Nutex Health [NUTX] vs HCA Healthcare [HCA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Nutex Health Inc. wins in 10 metrics, HCA Healthcare Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Nutex Health Inc. HCA Healthcare Inc. Better
P/E Ratio (TTM) 10.34 16.86 Nutex Health Inc.
Price-to-Book Ratio 2.33 -38.44 Nutex Health Inc.
Debt-to-Equity Ratio 82.99 -17.57 Nutex Health Inc.
PEG Ratio 5.33 0.37 HCA Healthcare Inc.
EV/EBITDA 2.46 10.08 Nutex Health Inc.
Profit Margin (TTM) 8.09% 8.97% HCA Healthcare Inc.
Operating Margin (TTM) 97.52% 16.29% Nutex Health Inc.
EBITDA Margin (TTM) 97.52% 16.29% Nutex Health Inc.
Return on Equity 58.94% -244.82% Nutex Health Inc.
Return on Assets (TTM) 31.18% 12.44% Nutex Health Inc.
Free Cash Flow (TTM) $245.60M $7.69B HCA Healthcare Inc.
Dividend Yield N/A 0.59% N/A
1-Year Return -23.03% -0.75% HCA Healthcare Inc.
Price-to-Sales Ratio (TTM) 0.88 1.39 Nutex Health Inc.
Enterprise Value $1.02B $156.18B HCA Healthcare Inc.
EV/Revenue Ratio 1.16 2.07 Nutex Health Inc.
Gross Profit Margin (TTM) 30.42% 41.90% HCA Healthcare Inc.
Revenue per Share (TTM) $138 $320 HCA Healthcare Inc.
Earnings per Share (Diluted) $10.48 $27.94 HCA Healthcare Inc.
Beta (Stock Volatility) 2.03 1.37 HCA Healthcare Inc.
Short % of Float 22.39% 2.45% HCA Healthcare Inc.

Nutex Health Inc. vs HCA Healthcare Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nutex Health Inc.6.24%11.20%-9.74%18.70%0.82%-10.37%
HCA Healthcare Inc.-1.12%-7.37%-14.97%-32.96%-25.38%-22.78%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nutex Health Inc.-23.03%90.34%-90.45%-90.45%-90.45%-90.45%
HCA Healthcare Inc.-0.75%38.02%77.08%384.44%1,008.79%1,116.39%

Performance & Financial Health Analysis: Nutex Health Inc. vs HCA Healthcare Inc.

MetricNUTXHCA
Market Information
Market Cap i$772.96M$106.00B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i194,554795,641
90 Day Avg. Volume i186,735974,074
Last Close$132.83$363.23
52 Week Range$77.21 - $193.07$330.00 - $556.52
% from 52W High-31.20%-34.73%
All-Time High$5,250.00 (Apr 04, 2022)$556.52 (Mar 12, 2026)
% from All-Time High-97.47%-34.73%
Growth Metrics
Quarterly Revenue Growth-0.41%0.07%
Quarterly Earnings Growth-0.81%0.31%
Financial Health
Profit Margin (TTM) i0.08%0.09%
Operating Margin (TTM) i0.98%0.16%
Return on Equity (TTM) i0.59%-2.45%
Debt to Equity (MRQ) i82.99-17.57
Cash & Liquidity
Book Value per Share (MRQ)$46.49$-26.83
Cash per Share (MRQ)$26.63$5.11
Operating Cash Flow (TTM) i$248.12M$12.64B
Levered Free Cash Flow (TTM) i$152.81M$5.82B
Dividends
Last 12-Month Dividend Yield iN/A0.59%
Last 12-Month Dividend iN/A$2.94

Valuation & Enterprise Metrics Analysis: Nutex Health Inc. vs HCA Healthcare Inc.

MetricNUTX (Apr 24, 2026)HCA (Apr 23, 2026)
Price Ratios
P/E Ratio (TTM) i10.3416.86
Forward P/E i5.3314.13
PEG Ratio i5.330.37
Price to Sales (TTM) i0.881.39
Price to Book (MRQ) i2.33-38.44
Market Capitalization
Market Capitalization i$772.96M$106.00B
Enterprise Value i$1.02B$156.18B
Enterprise Value Metrics
Enterprise to Revenue i1.162.07
Enterprise to EBITDA i2.4610.08
Risk & Other Metrics
Beta i2.031.37
Book Value per Share (MRQ) i$46.49$-26.83

Financial Statements Comparison: Nutex Health Inc. vs HCA Healthcare Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNUTX (2025)HCA (2025)
Revenue/Sales i875.26M75.60B
Cost of Goods Sold i430.98M44.23B
COGS % of Revenue i49.2%58.5%
Gross Profit i444.28M31.37B
Gross Margin i50.8%41.5%
Research & Development iN/AN/A
Operating Income (EBIT) i275.63M11.97B
Operating Margin i31.5%15.8%
EBITDA i287.54M15.57B
EBITDA Margin i32.9%20.6%
Pre-Tax Income i244.78M9.83B
Pre-Tax Income % of Revenue i28.0%13.0%
Income Tax i64.42M2.05B
Income Tax % of Revenue i7.4%2.7%
Net Income (Profit) i180.36M7.78B
Profit Margin i20.6%10.3%

Balance Sheet & Liquidity Metrics

MetricNUTX (2025)HCA (2025)
Cash & Equivalents i185.57M1.04B
Total Current Assets i538.81M15.78B
Total Current Assets % of Revenue i61.6%20.9%
Total Current Liabilities i157.91M16.35B
Total Current Liabilities % of Revenue i18.0%21.6%
Long-Term Debt i328.09M43.46B
Long-Term Debt % of Revenue i37.5%57.5%
Total Shareholders Equity i423.44M-2.77B
Retained Earnings i-286.19M-5.72B
Retained Earnings % of Revenue i-32.7%-7.6%
Property, Plant & Equipment i287.01M39.12B

Cash Flow Statement Comparison

MetricNUTX (2025)HCA (2025)
Operating Cash Flow i284.80M12.01B
Operating Cash Flow % of Revenue i32.5%15.9%
Capital Expenditures i-2.53M-4.94B
Free Cash Flow i245.60M7.69B
FCF Margin i28.1%10.2%
Debt Repayment i-24.48M-7.39B
Common Stock Repurchase i-5.00M-10.07B

Short Interest & Institutional Ownership Analysis

MetricNUTXHCA
Shares Short i994,3413.63M
Short Ratio i4.523.37
Short % of Float i22.39%2.45%
Shares Outstanding i7.09M224.61M
Float Shares i3.94M151.19M
% Held by Insiders i28.66%16.16%
% Held by Institutions i40.16%78.70%
% Held by Public i31.18%5.14%

Dividend Analysis & Yield Comparison: Nutex Health Inc. vs HCA Healthcare Inc.

MetricNUTXHCA
Last 12-Month Dividend iN/A$2.94
Last 12-Month Dividend Yield iN/A0.59%
3-Year Avg Annual Dividend iN/A$2.70
3-Year Avg Dividend Yield iN/A0.19%
3-Year Total Dividends iN/A$8.10
Ex-Dividend DateN/AMar 17, 2026